DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Shaw AT, Kim TM, Crinò L. et al.
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol 2017;
18 (07) 874-886
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.